Table 5 ES2 cells tend to present a stronger resistance to carboplatin than OVCAR3 cells
A. | |
Treatments – cell death analysis (48 h) | T test sig. |
ES2-AN vs OVCAR3-AN | 0.001 |
ES2-ANC vs OVCAR3-ANC | 0.347 |
ES2-AH vs E OVCAR3-AH | 0.000 |
ES2-AHC vs OVCAR3-AHC | 0.179 |
B. | |
Treatments – cell death analysis (48 h) | T test sig. |
ES2-NN vs OVCAR3-NN | 0.003 |
ES2-NNC vs OVCAR3-NNC | 0.085 |
ES2-NH vs E OVCAR3-NH | 0.007 |
ES2-NHC vs OVCAR3-NHC | 0.092 |
C. | |
Treatments – cell death analysis (48 h) | T test sig. |
ES2-HN vs OVCAR3-HN | 0.000 |
ES2-HNC vs OVCAR3-HNC | 0.000 |
ES2-HH vs E OVCAR3-HH | 0.000 |
ES2-HHC vs OVCAR3-HHC | 0.000 |